Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.
about
New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small moleculesEnhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for CancerQKI-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferationPoly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damage-independent roles.PARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation.Low doses of 3-aminobenzamide, a poly(ADP-ribose) polymerase inhibitor, stimulate angiogenesis by regulating expression of urokinase type plasminogen activator and matrix metalloprotease 2.PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1.The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest.PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expressionDeciphering the insights of poly(ADP-ribosylation) in tumor progression.Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.Targeted Tumor Therapy Remixed-An Update on the Use of Small-Molecule Drugs in Combination Therapies.
P2860
Q28486776-AEB12A86-5C0B-4985-A17B-EA58D18EF01DQ29147555-AE69B46E-E1CC-4FAD-B034-494020DE859EQ34208257-1DD1C5C0-81DC-45C4-91B6-D403A58788FCQ34447606-58C8D408-4CB0-49E9-B35E-D1DCCA583040Q34778528-FD06A801-06F1-4446-B155-9D865FA5D804Q35052831-143BCB62-6EA4-4039-AA79-B004FB1DA3B7Q35186284-A8272509-463D-4360-9CCA-5AD55835D522Q35255891-AB46CD1B-A077-442E-A1FA-BC96B257BA49Q36020900-38FF0000-9B58-432C-A3C4-B051BB345C2FQ38325685-068D7ABA-DF36-4FA7-8776-A0D71CE88DBFQ39549717-7A203794-CC27-4958-BAD4-EDC8982A464EQ54978342-F6E2C25B-ECB7-476F-A260-D7303C86A67F
P2860
Inhibition of PARP activity by PJ-34 leads to growth impairment and cell death associated with aberrant mitotic pattern and nucleolar actin accumulation in M14 melanoma cell line.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@en
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@nl
type
label
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@en
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@nl
prefLabel
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@en
Inhibition of PARP activity by ...... ion in M14 melanoma cell line.
@nl
P2093
P2860
P50
P356
P1476
Inhibition of PARP activity by ...... tion in M14 melanoma cell line
@en
P2093
Carmen D'Angelo
Gabriella Zupi
Marta Chevanne
Paola Caiafa
Riccardo Caldini
P2860
P304
P356
10.1002/JCP.21964
P50
P577
2010-02-01T00:00:00Z